PerkinElmer Announces Purchase Price for Tender Offer and Consent Solicitation
BOSTON—PerkinElmer, Inc. (NYSE: PKI) announced today that it has determined the purchase price to be paid in connection with its previously announced cash tender offer and consent solicitation for any and all of its outstanding 8 7/8% Senior Subordinated Notes due 2013 and that $269.891 million, or 99.96% of the aggregate outstanding principal amount of notes were validly tendered. The tender offer and the consent solicitation are subject to the terms and conditions set forth in PerkinElmer’s Offer to Purchase and Consent Solicitation Statement dated October 25, 2005.
Holders of notes who validly tender notes prior to the initial settlement date will receive total consideration per $1,000 principal amount of notes tendered of $1,119.64, which amount includes a consent payment of $20, plus accrued and unpaid interest up to the date of the payment. Holders of notes will validly tender notes on the initial settlement date and prior to the expiration time of 9:00 a.m., New York City time, on November 23, 2005, will receive total consideration per $1,000 principal amount of notes tendered of $1,118.65, which amount also includes a consent payment of $20, plus accrued and unpaid interest up to the date of payment. The consent payment will be paid for all validly tendered notes, including those tendered subsequent to the November 7, 2005 consent deadline. The purchase price for the notes was calculated in the manner described in the Offer to Purchase using a yield equal to a fixed spread of 50 basis points plus 4.448%, which is the yield to maturity of the 3.000% U.S. Treasury Note due February 15, 2008 (corresponding to the bid-side price, as indicated on Bloomberg screen PX5 at 2:00 p.m., New York City time, on November 8, 2005).
PerkinElmer may elect to accept for payment all notes validly tendered on the initial settlement date, which is to occur promptly after today’s pricing. PerkinElmer anticipates that the initial settlement date may be November 14, 2005. However, PerkinElmer reserves the right, in its sole discretion, to extend or forgo the initial settlement date. The tender offer will expire at 9:00 a.m., New York City time, on November 23, 2005, unless extended, and PerkinElmer expects the final settlement date, if any, to occur promptly after the expiration of the tender offer.
All withdrawal rights of tendering holders of notes terminated at 5:00 p.m., New York City time, on November 7, 2005. Accordingly, tendering holders may no longer withdraw their notes, unless PerkinElmer permits them to do so. Holders who have not yet tendered their notes may tender at or prior to 9:00 a.m., New York City time, on November 23, 2005.
Citigroup Corporate and Investment Banking and Goldman Sachs & Co. are acting as the dealer managers for the tender offer and the consent solicitation. Global Bondholder Services Corporation is serving as the depositary and information agent for the tender offer and consent solicitation.
Holders should consult the Offer to Purchase and related materials in their entirety for a full description of the terms and conditions of the tender offer and the consent solicitation. Requests for documents relating to the tender offer and consent solicitation may be directed to Global Bondholder Services Corporation by telephone at 1-866 470-4500 or 1-212 430-3774 or in writing at 65 Broadway, Suite 704, New York, NY 10006. Questions regarding the tender offer and consent solicitation may be directed to Citigroup Corporate and Investment Banking, Liability Management Group, at 1-800-558-3745 or 1-212-723-6106 or to Goldman, Sachs & Co., Credit Liability Management Group, at 1-800 828-3182 or 1-212-357-7867.
This news release is neither an offer to purchase nor a solicitation of an offer to sell the notes. The tender offer is being made only pursuant to the Offer to Purchase, which PerkinElmer has distributed to holders of the notes.
PerkinElmer is a global technology leader driving growth and innovation in Health Sciences and Photonics markets to improve the quality of life. PerkinElmer reported revenues of $1.7 billion in 2004, has 10,000 employees serving customers in more than 125 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.